002074 国轩高科
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入11,708,08729.30%45,070,46235,391,81731,605,49023,051,701
减:营业总成本11,582,92431.24%44,351,35434,519,14731,492,00623,008,494
    其中:营业成本9,828,17032.82%37,780,36929,020,13126,620,63118,949,696
               财务费用582,40868.11%1,442,765842,650547,493322,672
               资产减值损失(21,749)-34.61%(283,524)(399,010)(244,369)(372,035)
公允价值变动收益(294,296)440.26%1,922,166196,190105,891(139,874)
投资收益(1,826)-103.33%145,78947,19468,685217,176
    其中:对联营企业和合营企业的投资收益20,489-2,296.56%(66,408)(85,206)(281)72,124
营业利润(734)-100.71%2,345,1111,283,450975,425198,694
利润总额(14,963)-115.08%2,253,3261,263,110948,160258,964
减:所得税费用(40,030)1,337.60%(35,093)108,976(20,939)(106,676)
净利润25,067-75.43%2,288,4191,154,134969,099365,640
减:非控股权益3,974182.02%(94,853)(52,656)30,37254,064
股东净利润21,093-79.04%2,383,2721,206,790938,727311,576

市场价值指针
每股收益 (元) *0.010-83.33%1.3200.6800.5300.180
每股派息 (元) *----0.1000.1000.100--
每股净资产 (元) *15.94810.93%16.05414.40614.04213.217
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容